ask="51.50"
ask_size="100"
average_daily_volume="398758"
bid="41.75"
bid_size="100"
book_value="14.89"
change="-2.58"
change_from_200_day_moving_average="-6.62"
change_from_50_day_moving_average="-8.00"
change_from_52_week_high="-17.48"
change_From_52_week_low="15.49"
change_in_percent="-5.60%"
close="43.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="46.19"
high_52_weeks="60.98"
last_trade_date="1/20/2017"
last_trade_price="43.50"
last_trade_size="21159"
last_trade_time="4:00pm"
low="43.22"
low_52_weeks="28.01"
market_capitalization="1.18B"
moving_average_200_day="50.12"
moving_average_50_day="51.50"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="46.00"
pe_ratio="4.86"
peg_ratio="0.36"
percent_change_from_200_day_moving_average="-13.20%"
percent_change_from_50_day_moving_average="-15.53%"
percent_change_from_52_week_high="-28.67%"
percent_change_from_52_week_low="+55.30%"
previous_close="46.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.10"
price_per_sales="3.24"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.09"
stock_exchange="NMS"
symbol="FPRX"
volume="459545"
weeks_range_52="28.01 - 60.98"
